FDA Advisory Panel Backs Cameron's New Defibrillators

Law360, New York (April 26, 2012, 10:09 PM EDT) -- Cameron Health Inc. announced Thursday that a U.S. Food and Drug Administration advisory panel had voted overwhelmingly to recommend that the FDA approve its new implantable defibrillators, despite mixed feedback in an agency report released earlier this week.

The Circulatory System Devices Panel of the FDA's Medical Devices Advisory Committee voted 7-1 that there's sufficient data about the efficacy and safety of Cameron's S-ICD System, a subcutaneous, implantable cardio-defibrillator for treating sudden cardiac arrest. The prime selling point of the subcutaneous defibrillator is that it’s relatively noninvasive,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.